Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 4.2B | 3.7B | 3.8B | 3.2B |
Cost of revenue | 2.2B | 2.0B | 2.0B | 1.8B |
Gross profit | 2.0B | 1.7B | 1.8B | 1.5B |
Operating expense | ||||
Research & development | 256M | 215M | 201M | 213M |
Selling general and admin | 1.3B | 1.3B | 1.3B | 1.2B |
Other operating expenses | — | — | — | — |
Operating income | 389M | 223M | 279M | 97M |
Non operating interest income | ||||
Income | 20M | 20M | 18M | — |
Expense | 130M | 105M | 112M | 105M |
Other income expense | — | — | — | — |
Pretax income | 205M | 354M | -42M | -130M |
Tax provision | 168M | 19M | -198M | -16M |
Net income | 37M | 335M | 156M | -114M |
Basic EPS | 0.6 | 1.6 | 0.5 | -0.6 |
Diluted EPS | 0.6 | 1.6 | 0.5 | -0.6 |
Basic average shares | 179M | 180M | 180M | 178M |
Diluted average shares | 179M | 180.3M | 180M | 178M |
EBITDA | 802M | 545M | 553M | 233M |
Net income from continuing op. | 37M | 335M | 156M | -114M |
Minority interests | -12M | -3M | -26M | -5M |
Preferred stock dividends | -80M | 49M | 49M | -16M |